Generali Asset Management SPA SGR Makes New $1.66 Million Investment in Corteva, Inc. (NYSE:CTVA)

Generali Asset Management SPA SGR purchased a new stake in Corteva, Inc. (NYSE:CTVA - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm purchased 29,123 shares of the company's stock, valued at approximately $1,659,000.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Flagship Wealth Advisors LLC bought a new position in shares of Corteva during the fourth quarter worth $25,000. Noble Wealth Management PBC bought a new position in Corteva during the fourth quarter worth about $26,000. Hager Investment Management Services LLC acquired a new position in Corteva in the fourth quarter valued at about $27,000. Golden State Wealth Management LLC acquired a new position in shares of Corteva in the 4th quarter valued at approximately $32,000. Finally, Centricity Wealth Management LLC bought a new position in Corteva in the fourth quarter valued at approximately $34,000. Institutional investors own 81.54% of the company's stock.

Insider Activity

In other Corteva news, insider Brian Titus sold 26,560 shares of the stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $63.74, for a total value of $1,692,934.40. Following the transaction, the insider now directly owns 11,347 shares of the company's stock, valued at $723,257.78. This represents a 70.07 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.14% of the company's stock.

Remove Ads

Corteva Stock Performance

NYSE:CTVA traded down $0.16 during mid-day trading on Tuesday, hitting $61.91. The stock had a trading volume of 2,565,179 shares, compared to its average volume of 3,045,209. Corteva, Inc. has a twelve month low of $50.01 and a twelve month high of $66.24. The company has a debt-to-equity ratio of 0.08, a quick ratio of 0.93 and a current ratio of 1.45. The stock has a market cap of $42.44 billion, a price-to-earnings ratio of 47.99, a PEG ratio of 1.68 and a beta of 0.79. The company's 50 day simple moving average is $62.48 and its 200 day simple moving average is $59.95.

Corteva (NYSE:CTVA - Get Free Report) last issued its earnings results on Wednesday, February 5th. The company reported $0.32 EPS for the quarter, missing the consensus estimate of $0.34 by ($0.02). Corteva had a return on equity of 7.19% and a net margin of 5.36%. On average, equities research analysts forecast that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Monday, March 3rd were given a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 1.10%. The ex-dividend date of this dividend was Monday, March 3rd. Corteva's payout ratio is presently 52.71%.

Analysts Set New Price Targets

A number of brokerages recently commented on CTVA. BNP Paribas upgraded shares of Corteva to a "hold" rating in a report on Monday, February 10th. KeyCorp boosted their price target on Corteva from $68.00 to $70.00 and gave the company an "overweight" rating in a report on Friday, February 7th. Bank of America increased their price objective on Corteva from $69.00 to $73.00 and gave the stock a "buy" rating in a report on Tuesday, February 11th. Oppenheimer boosted their target price on Corteva from $70.00 to $72.00 and gave the company an "outperform" rating in a research note on Friday, February 7th. Finally, Wells Fargo & Company lifted their price objective on shares of Corteva from $67.00 to $73.00 and gave the company an "overweight" rating in a report on Tuesday, January 28th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $68.00.

Corteva Company Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.